Renal expression of exchange protein directly activated by cAMP (Epac) 1 and 2. by Li, Y. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/71173
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
doi:10.1152/ajprenal.00448.2007
 295:F525-F533, 2008. First published 21 May 2008;Am J Physiol Renal Physiol
M. T. Deen
Yuedan Li, Irene B. M. Konings, Jun Zhao, Leo S. Price, Emile de Heer and Peter
by cAMP (Epac) 1 and 2
Renal expression of exchange protein directly activated
You might find this additional info useful...
38 articles, 25 of which can be accessed free at:This article cites 
 http://ajprenal.physiology.org/content/295/2/F525.full.html#ref-list-1
5 other HighWire hosted articlesThis article has been cited by 
 
 [PDF] [Full Text] [Abstract]
, September , 2009; 20 (9): 2018-2024.JASN
Pech, Susan M. Wall and Jeff M. Sands
Yanhua Wang, Janet D. Klein, Mitsi A. Blount, Christopher F. Martin, Kimilia J. Kent, Vladimir
Epac Regulates UT-A1 to Increase Urea Transport in Inner Medullary Collecting Ducts
 
 [PDF] [Full Text] [Abstract]
, September 11, 2009; 284 (37): 24965-24971.J. Biol. Chem.
Paulo S. Caceres, Gustavo R. Ares and Pablo A. Ortiz
the Thick Ascending Limb : ROLE OF PROTEIN KINASE A
 Cotransporter NKCC2 in−-2Cl+-K+cAMP Stimulates Apical Exocytosis of the Renal Na
 
 [PDF] [Full Text] [Abstract]
, May , 2011; 22 (5): 859-872.JASN
Bos, Ingeborg M. Bajema, Bob van de Water and Leo S. Price
Geurt Stokman, Yu Qin, Hans-Gottfried Genieser, Frank Schwede, Emile de Heer, Johannes L.
Epac-Rap Signaling Reduces Cellular Stress and Ischemia-induced Kidney Failure
 
 [PDF] [Full Text] [Abstract]
, June 1, 2012; 302 (11): F1395-F1401.Am J Physiol Renal Physiol
Wetzels and Peter M. T. Deen
Marleen L. A. Kortenoeven, Christiane Trimpert, Michiel van den Brand, Yuedan Li, Jack F. M.
of protein kinase A and CREB but may involve Epac
In mpkCCD cells, long-term regulation of aquaporin-2 by vasopressin occurs independent
 
 [PDF] [Full Text] [Abstract]
, July , 2012; 49 (4): 693-703.Vet Pathol
L. E. Brandt, A. A. Bohn, J. B. Charles and E. J. Ehrhart
Localization of Canine, Feline, and Mouse Renal Membrane Proteins
including high resolution figures, can be found at:Updated information and services 
 http://ajprenal.physiology.org/content/295/2/F525.full.html
 can be found at:AJP - Renal Physiologyabout Additional material and information 
http://www.the-aps.org/publications/ajprenal
This information is current as of July 11, 2012.
 
American Physiological Society. ISSN: 1931-857X, ESSN: 1522-1466. Visit our website at http://www.the-aps.org/.
(monthly) by the American Physiological Society, 9650 Rockville Pike, Bethesda MD 20814-3991. Copyright © 2008 by the
respective cells and vasculature, as well as to the control of body fluid volume and composition. It is published 12 times a year 
 publishes original manuscripts on a broad range of subjects relating to the kidney, urinary tract, and theirAJP - Renal Physiology
 o
n
 July 11, 2012
ajprenal.physiology.org
D
ow
nloaded from
 
Renal expression of exchange protein directly activated by cAMP
(Epac) 1 and 2
Yuedan Li,1 Irene B. M. Konings,1 Jun Zhao,2 Leo S. Price,2 Emile de Heer,3 and Peter M. T. Deen1
1Department of Physiology, Radboud University Nijmegen Medical Centre, Nijmegen; 2Department of Physiological
Chemistry and Centre for Biomedical Genetics, University Medical Centre Utrecht, Utrecht; and 3Department of Pathology,
Leiden University Medical Center, Leiden, The Netherlands
Submitted 26 September 2007; accepted in final form 20 May 2008
Li Y, Konings IB, Zhao J, Price LS, de Heer E, Deen PM. Renal
expression of exchange protein directly activated by cAMP (Epac) 1
and 2. Am J Physiol Renal Physiol 295: F525–F533, 2008. First
published May 21, 2008; doi:10.1152/ajprenal.00448.2007.—In the
kidney, many physiological processes of ion transport and cellular
proliferation are mediated via cAMP, which classically activates
protein kinase A (PKA). Recently, however, two new cAMP targets,
the exchange protein directly activated by cAMP (Epac) 1 and 2, were
identified, which mediate alternative pathways to PKA. To investigate
their renal expression, antibodies specifically recognizing Epac1 and
Epac2 were generated and used in rat immunohistochemistry with
antibodies recognizing aquaporin-1 (AQP1), Tamm-Horsfall protein,
Calbindin-D28K, and AQP2 to mark proximal tubules (PT)/thin de-
scending limbs of Henle’s loop (tDLH), thick ascending limbs of
Henle’s loop (TAL), distal convoluted tubule/connecting tubule
(DCT/CNT), and the collecting duct (CD) principal cells, respec-
tively. Epac1 and Epac2 were expressed at the brush border of PT
cells but were absent from tDLH cells. In the TAL, Epac1 and Epac2
were expressed throughout the cells with some confinement toward
the apical membrane. In the DCT/CNT, Epac1 was confined to the
apical region of the cells, whereas Epac2 was mainly expressed in the
apical and basolateral regions. In the CD, a dispersed Epac1 expres-
sion was found in intercalated cells only (cortical CD), principal and
intercalated cells [outer medullary CD (OMCD)], and mainly AQP2-
negative cells in the inner medullary CD (IMCD). In contrast, Epac2
expression was at the apical and basolateral membrane of cortical
principal cells, dispersed and apical in the OMCD, and in all cells of
the IMCD. A similar distribution for Epac1/2 was found in the human
kidney. The observed expression in different tubular segments sug-
gests a major role for Epac 1/2 in tubular transport physiology and
cellular proliferation.
kidney; localization
CYCLIC ADENOSINE MONOPHOSPHATE (cAMP) is a common second
messenger controlling many cellular processes. Protein kinase
A (PKA) is a general acceptor for cAMP, resulting in the
phosphorylation of a large variety of cellular targets. A newly
described cAMP target, exchange protein directly activated by
cAMP (Epac) 1, and its close relative Epac2 contain cAMP-
binding domains very similar to the cAMP-binding domains in
the regulatory subunit of PKA and activate specifically the
monomeric G proteins of Ras family, Rap1 and Ras (6, 22).
Many actions of cAMP, which were thought to be mediated
exclusively by PKA, are now found to be likely mediated
through Epac, including integrin-mediated cell adhesion (29),
vascular endothelial cell barrier formation (13, 25), cardiac gap
junction formation (32), mitogen-activated protein kinase
(MAPK) signaling (34), hormone gene expression (14), and
phospholipase C-ε (PLC-ε) activation (16, 30). Intriguingly,
newly published findings demonstrate that Epac-mediated ac-
tions of cAMP influence Na, K, Ca2, and Cl channel
function (1, 15, 20), Na/H and Na/K transporter activity,
and exocytosis in multiple cell types (17, 19, 37).
Interestingly, the kidney is one of the organs that shows the
highest levels of expression of mRNAs encoding Epac1 (6),
especially in the collecting ducts, suggesting an important role
of Epac in cAMP signaling mechanisms in the kidney. There-
fore, to identify which renal segments might involve Epac1 or
2 in their cellular processes, we investigated the localization of
Epac1 and 2 in the rat kidney.
MATERIALS AND METHODS
Cell culture. Human embryonic kidney 293 (HEK293) cells were
grown in DMEM supplemented with 10% (vol/vol) fetal calf serum at
37°C in 5% CO2 and transiently transfected with the empty expression
vector pcDNA3, or those containing Flag-tag full-length human
Epac1 (GI: 3978530) cDNA or Flag-tag full-length mouse Epac2 (GI:
9790086) cDNA using polyethylenimine (Polysciences). HEK293
cells were seeded on polylysine-coated glass slides in 12-well plate
(Corning Costar, Cambridge, MA) at a density of 1  105 cells/ well.
The medium was refreshed and the cells were transfected 3 h later.
The transfection mix for each well consisted of 1 g cDNA and 6 l
polyethylenimine (1 g/l) in a total volume of 30 l Opti-MEM
(Invitrogen). It was incubated for 20 min at room temperature and
added to the cells. After an overnight incubation at 37°C, the medium
was refreshed and the cells were grown for 23 days.
Tissue preparation. Male Wistar rats were obtained from the Uni-
versity Animal Facility, Radboud University Nijmegen Medical Centre.
Following anesthesia with isofluorothane, the rats were killed after which
the kidneys were rapidly removed, fixed in 1% (wt/vol) periodate-lysine-
paraformaldehyde (PFA) for 2 h and 15% (wt/vol) sucrose in PBS for
16 h, fast frozen in liquid nitrogen and stored at 80°C.
Human donor kidneys were provided by Eurotransplant. These kid-
neys had not been transplanted for technical reasons (branching of the
renal artery), but showed no histological abnormalities. The warm ische-
mia time of these kidneys was 88 min, and the cold ischemia time was
32 h. These kidneys did not show significant signs of ischemia-
reperfusion injury (2, 3). All samples were obtained after informed
consent of the donors. Their use was approved by the medical ethical
committee of Eurotransplant. Kidney cortex and medulla samples
were fixed in 4% buffered formalin and embedded in paraffin.
Antibodies. For Epac detection, a cDNA fragment encoding human
Epac1 (GI: 3978530) except for amino acids 1–148 (DEP-Epac1)
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and a cDNA fragment encoding mouse Epac2 (GI: 9790086) except
for amino acids 1–279 (DEP-Epac2) were cloned into the pGEX
expression vector to produce recombinant proteins. Rabbits were
immunized with the GST-coupled DEP-Epac1 or DEP-Epac2
recombinant proteins and, after development of proper antibody titres,
the rabbits were bled. Polyclonal rabbit anti-serum 2293 was used to
detect Epac1; rabbit polyclonal anti-serum 2295 was used to detect
Epac2. Preimmune sera were used as negative controls. Mouse mono-
clonal anti-Flag antibody (M2; Sigma, St. Louis, MO) was used to
detect the Flag-Epac proteins in transfected HEK293 cells.
As primary antibodies against renal segment marker proteins, we
used mouse monoclonal aquaporin-1 (AQP1) antibodies (kindly pro-
vided by Dr. Jennings, University of Texas, Galveston, TX) to detect
proximal tubules (PT) and thin descending limbs of Henle’s loop
(tDLH), polyclonal goat Tamm-Horsfall protein (THP) antibodies
(ICN Biomedicals, Aurora, OH) to reveal the thick ascending limbs of
Henle’s loop (TAL), mouse monoclonal Calbindin-D28K antibodies
(Swant, Bellinzona, Switzerland) to detect the distal convoluted tu-
bule (DCT) and connecting tubule (CNT), and affinity-purified guinea
pig 9 AQP2 antibodies, raised against the last 15 amino acids of the
AQP2 COOH terminus (7) to reveal the principal cells of the collect-
ing duct. Mouse monoclonal anti--actin antibodies were from Sigma.
As secondary antibodies, Alexa 594-conjugated goat anti-mouse,
donkey anti-goat, or goat anti-guinea pig antibodies were used to
detect AQP1, THP, Calbindin-D28K, and AQP2. Alexa 488-conju-
gated goat anti-rabbit were used to detect Epac1 and 2 on the kidney
sections. All secondary antibodies were purchased from Molecular
Probes (Leiden, The Netherlands).
Immunoblotting. Transfected HEK293 cells from 12-well plate
were lysed in 200 l Laemmli buffer/well and 15-l samples were
analyzed. PAGE, blotting, and blocking of the PVDF membranes
were done as described (18). Membranes were incubated for 16 h with
1:1,000 diluted polyclonal rabbit anti-Epac1 or Epac2 antibodies, or
1:1,000 diluted monoclonal mouse anti-Flag antibody, in Tris-buff-
ered saline Tween 20 (TBS-T) supplemented with 5% nonfat dried
milk. Blots were incubated for 1 h with 1:5,000 diluted goat anti-
rabbit IgGs or 1:2,000 goat anti-mouse IgGs (Sigma) as secondary
antibodies coupled to horseradish peroxidase. Proteins were visual-
ized using enhanced chemiluminescence (ECL, Pierce, Rockford, IL).
Equal loading of the samples was confirmed by parallel immunoblot-
ting against 1:25,000 diluted mouse -actin antibody.
Immunocytochemistry and immunohistochemistry. For immuno-
cytochemistry, transfected HEK293 cells were washed twice with
PBS-CM (PBS with 0.1 mM CaCl2, 1 mM MgCl2) and fixed in 3%
paraformaldehyde for 30 min. Following quenching of aldehyde
groups with 50 mM NH4Cl in PBS for 15 min, cells were permeabil-
ized with 0.3% Triton X-100 in PBS for 15 min, incubated with goat
serum dilution buffer (GSDB; 16% goat serum, 0.3% Triton X-100,
0.3 M NaCl in PBS) for 30 min to block nonspecific antibody binding,
and incubated O/N with polyclonal rabbit anti-Epac1 or 2 antibody at
1:100 dilution in GSDB. After being washed twice with permeabili-
zation buffer (0.3% Triton X-100, 0.1% BSA in PBS), cells were
incubated with 1:100 diluted goat anti-rabbit antibodies coupled to
Alexa 488 in GSDB for 45 min. Next, cells were rinsed twice with
permeabilization buffer and mounted on glass slides with Mowiol.
For immunohistochemistry on 7-m cryosection of the rat kidney,
the following protocol was used. 1) For antigen retrieval, the sections
were immersed in boiled citrate target retrieval buffer [0.01 M sodium
citrate and 0.01 M citric acid (pH 6.0)] and left to cool for 30 min. 2)
To block nonspecific antibody binding, sections were incubated in
TN-B buffer [TN: 0.1 M Tris HCl (pH 7.6), 0.15 M NaCl; B: 0.5%
Blocking Reagent, Perkin Elmer Life Sciences, Boston, MA] for
30 min. 3) Sections were incubated O/N at 4°C with 1:100 diluted Epac1
or Epac2 antibodies or their preimmune sera. 4) Following three times
of 10-min washing with TN-T buffer (TN buffer with 0.05% Tween
20), the sections were incubated for 1 h at room temperature with
Alexa 488-conjugated goat anti-rabbit antibodies. 5) After being
washed, the sections were incubated with mouse AQP1 antibodies
(1:100), goat Tamm-Horsfall antibodies (1:200), mouse Calbindin-
D28K antibodies (1:100), or guinea pig AQP2 antibodies (1:50) for 1 h
at room temperature, followed by Alexa 594-conjugated goat anti-
mouse, donkey anti-goat, or goat anti-guinea pig antibodies for 1 h at
room temperature. 6) Sections were dehydrated and mounted in
Mowiol. Images were made by using Bio-Rad MRC-1024 confocal
laser-scanning microscopy (CLSM).
For the human kidneys, paraffin sections of 4-m thickness were
cut, deparaffinized, and rehydrated. For Epac1 staining, antigen re-
trieval was achieved by boiling sections in 10 mM Tris/1 mM EDTA
buffer at pH 8.0 for 10 min, followed by 20 min of cooling. For Epac2
staining, antigen retrieval was achieved by boiling sections in 10 mM
citrate buffer at pH 6.0 for 10 min, followed by 20 min of cooling.
Endogenous peroxidase was blocked by 0.3% H2O2. Subsequently,
the sections were incubated with rabbit anti-Epac1 (1:300), anti-Epac2
(1:150), or anti-AQP2 (1:50) for 1 h. After being rinsed, the sections
were incubated with anti-rabbit-Envision or anti-guinea pig-Envision
(Dako, Glostrup, Denmark), developed with diaminobenzidine and
Cu2SO4, and counterstained with hematoxylin. Subsequently, the
sections were dehydrated using increasing ethanol concentrations,
xylene, and mounted in malinol.
To check for the specificity of the anti-Epac1 and 2 immunostain-
ing on the rat sections, the Epac antibodies at the concentrations given
above were incubated O/N at 4°C with their antigenic GST-DEP-
Epac1 (15 mg/ml) or GST-DEP-Epac2 (5 mg/ml) recombinant
proteins before application. For the human sections, the anti-Epac1
and anti-Epac2 antibodies were first serially diluted until the next one
in two dilution step resulted in reduction of immunostaining. The
dilution of anti-Epac antibodies was incubated with a 10-fold molar
excess of either Epac1 or Epac2 recombinant protein for 4 h at 4°C
followed by immunostaining of normal human kidney paraffin sec-
tions. Control sections were incubated with unabsorbed antibodies at
the same dilution.
RESULTS
Specificity of the Epac1 and 2 antibodies. To test the spec-
ificity of rabbit polyclonal antibodies 2293 and 2295 for Epac1
and 2, respectively, HEK293 cells were transiently transfected
with F-Epac1 or F-Epac2 expression constructs. After 3 days,
the cells were fixed and subjected to immunocytochemistry
using these antibodies. CLSM revealed a clear staining with
the Epac1 antibodies in cells expressing F-Epac1, but not
F-Epac2 (Fig. 1A, top). Moreover, the Epac2 antibodies only
stained F-Epac2, but not F-Epac1, transfected cells (Fig. 1A,
bottom). In parallel, cells were scraped and lysed to test our
antibodies with immunoblotting. As shown in Fig. 1B, our
Epac1 antibodies specifically recognized a band at 96 kDa in
the lane loaded with F-Epac1 transfected cell material, which is
the anticipated size for F-Epac1. No signal was found in the
lanes loaded with samples derived from mock or F-Epac2
expressing cells (Fig. 1B). In contrast, our Epac2 antibodies
recognized a 116-kDa band in the lane loaded with F-Epac2
expressing material, which is in line with the anticipated mass
of F-Epac2. No such signals were obtained in lanes loaded with
lysates from mock or F-Epac1 expressing cells. Immunoblot-
ting with Flag antibody recognized the same bands for Epac1
and 2 in the cells. Similar -actin signals confirmed loading of
protein equivalents in each lane (Fig. 1B). These data indicated
that our rabbit polyclonal antibodies against Epac1 and Epac2
specifically recognize Epac1 and Epac2, respectively, when
used in immunocytochemistry and in immunoblotting.
F526 RENAL EXPRESSION OF Epac1 AND 2
AJP-Renal Physiol • VOL 295 • AUGUST 2008 • www.ajprenal.org
 o
n
 July 11, 2012
ajprenal.physiology.org
D
ow
nloaded from
 
To determine whether our Epac antibodies reveal specific
signals in the rat kidney, neighbouring sections were incubated
with 1:100 dilutions of these sera or their respective preim-
mune sera. Subsequent CLSM analysis revealed clear signals
with the anti-Epac1 antibodies and anti-Epac2 antibodies (Fig.
1C, left, arrows indicating positively stained renal tubules),
which were not seen with their respective preimmune sera (Fig.
1C, right, arrows indicating the same tubules as those in the
left). These data indicated that both antibodies reveal specific
Epac signals in the rat kidney. Furthermore, preabsorption of
the antibodies with their antigenic recombinant proteins fully
blocked the fluorescent signal (Fig. 1D, arrows indicating the
same tubules for both left and right), demonstrating the spec-
ificity of these antibodies.
Localization of Epac1 in rat kidney. To elucidate the renal
segmental localization of Epac1 and 2, coimmunohistochemi-
Fig. 1. Specificity of the Epac1 and 2 antibodies. A: F-Epac1 or F-Epac2 expressing human embryonic kidney 293 (HEK293) cells were immunostained with
rabbit Epac1 or 2 antibodies, followed by Alexa 488-conjugated goat-anti-rabbit secondary antibody. The cells were analyzed by confocal laser-scanning
microscopy (CLSM). Images are shown with a 180-fold magnification. B: lysates of mock-transfected or F-Epac1 or F-Epac2 expressing HEK293 cells were
separated by gel electrophoresis and immunoblotted for Epac1, Epac2, or the Flag tag, whereas immunoblotting for -actin was done to check equal loading.
C: rat kidneys were fixed with 3% paraformaldehyde (PFA), cryosections were made and incubated with rabbit Epac1 or Epac2 antibodies, or rabbit preimmune
serum, followed by Alexa 488-conjugated goat-anti-rabbit secondary antibody. D: consecutive cryosections were immunostained as in C with the rabbit Epac1
or 2 antibodies, or the antibodies were preabsorbed with their antigenic recombinant proteins. Images are shown with a 60-fold magnification. Arrows indicate
the tubules of inspection.
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Fig. 2. Expression of Epac1 in the rat kidney. Renal sections were doublelabeled for Epac1 (green) and aquaporin-1 (AQP1; red, A–C), Tamm-Horsfall protein
(THP; red, D), Calbindin-D28K (red, E), or AQP2 (red, F–H) and analyzed by CLSM. Images are shown with a 10- and 60-fold magnification. Arrows indicate
the tubules of inspection. Bold arrows indicate collecting duct (CD) principal cells, and arrowheads indicate CD intercalated cells.
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Fig. 3. Expression of Epac2 in the rat kidney. Renal sections were doublelabeled for Epac 2 (green) and AQP1 (red, A–C), THP (red, D), Calbindin-D28K (red,
E), or AQP2 (red, F–H) and analyzed by CLSM. Images are shown with a 10-, 30-, 60-, 120-, and 180-fold magnification. Arrows indicate the tubules of
inspection and apical membrane of the tubular cells, whereas double arrows indicate basolateral membrane. Arrowheads indicate connecting tubule (CNT)
intercalated cells.
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cal staining of rat kidney sections for Epac1 or 2 with nephron
segment marker proteins was performed. PT and tDLH express
AQP1, the TAL expresses THP, the DCT and CNT express
Calbindin-D28K, and principal cells of the collecting duct (CD)
express AQP2.
Double labeling of Epac1 with AQP1 revealed a colocaliza-
tion in 30% of the AQP1-positive PT in cortex (Fig. 2A), but
no expression of Epac1 in AQP1-positive segments of the outer
medulla (Fig. 2B). Interestingly, in all tubules stained with
Epac1, the signals were predominantly confined to the brush-
border membrane region of the cells (Fig. 2A, arrows). In the
inner medulla, AQP1-positive tDLH tubules did not show
Epac1-specific staining. Colabeling with THP showed that
Epac1 was expressed in all TAL cells (Fig. 2D). In these cells,
Fig. 4. Immunohistochemistry of Epac1 and Epac2 in the
human kidney. A: human renal sections were labeled by indirect
immunoperoxidase for Epac1 and Epac2 or the antibodies
preincubated with their antigenic recombinant proteins. Magni-
fication 10. B: human kidney sections of cortex and medulla
were immunelabeled as in A. Arrows indicate apical localiza-
tion of Epac1 and 2 on distal tubular epithelium (left) and
double arrows on CD (right). Bold arrows indicate cytoplas-
matic Epac2 in proximal epithelium and arrowheads in glomer-
ular visceral epithelium (left bottom). Magnification 20.
C: sequential human kidney sections were immunolabeled as in
A with Epac2 and AQP2 antibodies. Arrowheads indicate CD
intercalated cells. Magnification 100.
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Epac1 expression was spread throughout the cells, with a
somewhat stronger staining at the apical side of the cells (Fig.
2D, arrows). In the DCT and CNT, Epac1 was found in all
Calbindin-D28K-positive cells at only the apical region of the
cells, but its expression was clearly weaker than in the PT (Fig.
2E, arrows). In the CDs, Epac1 expression was found all along
the tubule (Fig. 2, F–H; bold arrows indicate principal cells and
arrowheads intercalated cells). In the cortex, Epac1 was found
in intercalated cells, in which it was evenly distributed. In the
outer medulla, Epac1 was mainly expressed in intercalated and
to some extent in (AQP2-positive) principal cells. In the inner
medulla, Epac1 was again mainly found in AQP2-negative
cells.
Localization of Epac2 in rat kidney. Double labeling of
Epac2 with AQP1 revealed a clear Epac2 expression in PT of
the cortex and outer medulla (Fig. 3, A and B; arrows). Its
expression was somewhat dispersed over the cell, but was
mainly localized at the brush-border side and sometimes also at
the basolateral side of the cells (double arrows). The identity
of the Epac2-positive structures in the lumen of the PT is unclear.
The AQP1-positive, tDLH-positive tubules of inner medulla
did not show staining for Epac2 (Fig. 3C).
Similar to Epac1, extensive expression of Epac2 was found
in the TAL as all THP-positive cells stained for Epac2 (Fig.
3D). Moreover, it had a dispersed vesicular-like expression
pattern and confinement to the apical side of the cells (arrows).
Epac2 was also found in the DCT and CNT, because it was
expressed in all Calbindin-D28K-positive tubular cells and
intercalated cells (Fig. 3C, arrows and arrowheads). In these
cells, Epac2 was found in the apical (arrow) and basolateral
(double arrow) region of the cells. In the CD, all AQP2-
positive cells stained for Epac2 (Fig. 3, F–H, arrows). In all
segments, Epac2 was also mainly found at apical regions of the
cells, with some expression throughout and at the basolateral
side of both intercalated and principal cells.
Localization of Epac1 and Epac2 in the human kidney. To
determine the localization of Epac1 and 2 in the human kidney,
it was first tested whether the antibodies would yield specific
staining. Indeed, following preabsorption of the antibodies
with their antigenic recombinant proteins, a complete absence
(Epac1) or a marked reduction (Epac2) of Epac1 and Epac2
staining on human kidney was observed (Fig. 4A). However,
virtually no inhibition of staining was observed, when anti-
Epac1 antibodies were incubated with Epac2, or vice versa (not
shown). The subsequent immunoperoxidase staining using
our Epac antibodies showed that the localization of Epac1 and
Epac2 was essentially similar to that in the rat kidney (Fig. 4B).
Epac1 was found in both proximal and distal epithelial cells,
TAL, and CD with a predominant apical distribution. Glomer-
ular epithelium only showed a weak staining. Peritubular
capillaries and glomerular endothelium were negative. Epac2
staining was observed in a similar apical distribution in renal
epithelia, but in addition showed some staining in visceral
epithelial cells in glomeruli. To investigate whether Epac2 in
the CD localized to principal or intercalated cells, consecutive
staining of Epac2 and AQP2 was performed (Fig. 4C). Similar
to that in the rat kidney, Epac2-positive staining was observed
in both AQP2-positive (principal) and AQP2-negative (inter-
calated; double arrowheads) cells in the CDs, with a predom-
inant expression to the apical membrane.
DISCUSSION
During the last years, an alternative pathway for cAMP
signaling has emerged with the identification of Epac1 and 2.
Considering the important role that this cascade plays in the
regulation of several different processes in the kidney, we set
out to determine the Epac1 and Epac2 protein expression in the
rat and human kidney. For this, we used rabbit polyclonal
antibodies 2293 and 2295, which were generated against hu-
man Epac1 and mouse Epac2, respectively. As shown in Fig. 1,
these antibodies specifically recognized Epac1 or 2 proteins
without cross-reacting to each other. Furthermore, they also
showed signals in the rat kidney, which were Epac-specific
because neither the preimmune sera nor the anti-sera after
preabsorption showed positive staining throughout the kidney.
Immunostaining of both Epac isoforms in human and rat
kidneys showed similar protein distribution.
Epac in the PT. Our immunohistochemistry revealed Epac1
and Epac2 expression throughout the nephron and CD (Fig. 5).
In line with the detected high expression of Epac1 mRNA (26)
Fig. 5. Summary of Epac1 and 2 localization in the kidney tubular cells. Epac1
and 2 localizations are listed in renal segments and cell types for rat (A) and
human (B). G, glomerular cells; PT, proximal tubule cells of cortex (c) or outer
medulla (o); tDLH, thin descending limb of Henle’s loop cells; TAL, thick
ascending limb of Henle’s loop cells; DCT/CNT, distal convoluted tubular and
connecting tubular cells; CCD, cortical collecting duct cells; OMCD, outer
medullary collecting duct cells; IMCD, inner medullary collecting duct cells;
mCD, medullary collecting duct cells; none, no staining observed.
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and the supposed functional implication of Epac1 in the
cAMP-mediated regulation of the Na/H exchanger 3
(NHE3) in the brush border (17, 26) of mouse PT, we found a
clear expression of Epac1 in the rat PT (Fig. 2A). The observed
pattern for Epac1 (and Epac2) appeared similar as found for
megalin, which is expressed in all three PT segments, but
mainly segments 1 and 2 (5). However, as the functional
effects on NHE3 were deduced from the response to an
Epac-specific agonist, and both Epac1 and Epac2 are found in
the apical region of PT (Figs. 2A and 3, A–B), the observed
effect might have also been mediated by Epac2. Interestingly,
ANG II has been shown to stimulate collagen synthesis in
mouse mesangial cells through a novel Epac-mediated phos-
phoinositide 3-kinase-dependent pathway (36). In the kidney,
ANG II increases sodium and bicarbonate reabsorption in the
apical membrane of the PT via AT1 receptors, in which Epac1
or 2 might also be involved. The structures in the center of the
tubules were seen for both Epac1 and 2 staining, although more
often for Epac2. At present, it is unclear to us whether these are
erythrocytes and/or tubular cells. Some of these structures
showed as cells with a round shape and are disconnected from
the tubules around them. These may be erythrocytes, as these
have been reported to express Epac (28). Others are more
irregular, are often connected with the tubules around them,
and may therefore be tubular microvilli.
Epac in the TAL. In the TAL, vasopressin induces apical
sodium entry by increasing the expression and activation of the
Na-K-2Cl cotransporter (NKCC2) and activation of the
Na-K-ATPase located in the basolateral membrane (23, 36).
Whereas activation of the sodium pump is ascribed to PKA-
mediated phosphorylation of its -subunit (33), Epac1 and
Epac2 might have a role in this process, as both are highly
expressed throughout this nephron segment (Figs. 2D and 3D).
Epac in the DCT and CNT. In the DCT and CNT, several
transport processes, such as the adenosine-induced uptake of
magnesium and TRPV5-mediated calcium reabsorption, are
known to be regulated by cAMP (8, 21). Both Epac1 and
Epac2 are found in these nephron segments with the confine-
ment at the cell membrane (Figs. 2E and 3E). It has to be
established whether they have a role in these processes.
Epac in the CD. In the kidney CD, several processes have
been suggested to involve Epac. In microdissected rat CCD,
Laroche-Joubert et al. (26) demonstrated that the H-K-
ATPase is activated through a cAMP-Epac1-Rap1-Raf-B-ERK
cascade in I intercalated cells. Involvement of Epac1, how-
ever, was again deduced from using an Epac1/2-specific ago-
nist. As we find expression of both Epac proteins in these cells
(Figs. 2F and 3F), our data suggest that the observed effect
could be mediated by Epac1 and/or Epac2.
Following incubation of rat inner medulla sections with the
Epac agonist 8-pCPT-2	-O-Me-cAMP, Yip (15, 38) found that
Epac is involved in the vasopressin-induced Ca2 mobilization
and translocation of AQP2 toward the apical membrane. Based
on immunocytochemical detection using only Epac1-specific
antibodies, Yip suggested that Epac1 mediates this response in
the inner medullary CD (IMCD). In line with our data (Fig.
2H), however, close examination of the particular figure of Yip
et al. reveals that his IMCD Epac1 expression is also mainly
confined to AQP2-negative cells. Although an involvement of
Epac1 cannot be excluded at this stage, the complete overlap of
Epac2 and AQP2 expression in the IMCD cells (Fig. 3H) may
suggest that Epac2, rather than Epac1, mediates the vasopres-
sin-induced calcium mobilization and AQP2 translocation in
the IMCD.
Interestingly, several data suggest that sodium reabsorption
through the epithelial sodium channel ENaC, which is ex-
pressed in the CNT and CD, might also involve Epac1 and 2.
It has been shown that in rat pulmonary cells, dopamine
increases the channel open probability (Po) of ENaC by a
cAMP-mediated alternative signaling pathway involving Epac
and Rap1 (27). Moreover, in Madin-Darby canine kidney cells
stably expressing ENaC, cAMP has been shown to increase the
short-circuit current (ISC) by increasing the surface expression
of ENaC, which is thought to occur through phosphorylation of
ENaC (31). In Xenopus laevis oocytes, however, the stimula-
tion by cAMP is abolished with the expression of recombinant
ENaC mutated at ERK phosphorylation motifs, but not of PKA
phosphorylation sites (24), which may suggest that cAMP
stimulates ENaC functioning through an Epac/ERK-mediated
phosphorylation of ENaC.
Epac in proliferation. Besides roles in mediating signaling
cascades regulating ion channels and transporters, the role of
Epac in cellular proliferation has also been suggested through
its activation of Rap1 in various organisms (6, 9–12). Inter-
estingly, several hormones, such as ANG II, AVP, and endo-
thelin, induce cellular renal proliferation through phosphory-
lation events. Moreover, cellular proliferation is a hallmark for
polycystic kidney disease and lithium-induced NDI, disorders
of (mostly) the CD in which cAMP has a critical role (4, 35).
It remains to be established, however, whether Epac has a
critical role in these physiological and pathophysiological
processes of cellular proliferation.
In conclusion, we established the renal localization of the
two Epac isoforms, 1 and 2. While the particular function of
each of these isoforms awaits further investigation, our data
provide a basis for further studies toward the elucidation of the
role of PKA or Epac proteins in cAMP-mediated processes of
ion transport and cellular proliferation in the kidney.
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